Medical marijuana does not reduce opioid deaths

Legalizing medical marijuana does not reduce the rate of fatal opioid overdoses, according to researchers at the Stanford University School of Medicine. The finding contradicts a 2014 study that legal-pot advocates, public officials and even physicians have touted as a reason to legalize marijuana. That study found lower rates of…

External reference drug pricing could save medicare tens of billions: Setting US drug prices based on prices paid in other countries could also improve affordability for Medicare beneficiaries

A new study by researchers at the Johns Hopkins Bloomberg School of Public Health found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the U.S. when compared with prices in the United Kingdom, Japan and the Canadian province of Ontario. The study also found that…

Lower costs associated with late-preterm steroid therapy: Study adds evidence to benefits of treatment for women at risk of delivery between 34th and 36th weeks

An analysis of a previous study has found more evidence to support giving the steroid betamethasone to pregnant women at risk of late-preterm delivery (between 34 and 36 weeks of gestation), according to a network funded by the National Institutes of Health. Hospital stays for infants whose mothers received the…